Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C J Springer

Showing results (31-40 of 63) with videos related to

Pageof 7
Sort By:
Clinica Chimica Acta; International Journal of Clinical Chemistry|May 15, 1991
Accelerated in vitro degradation of CCK-58 in blood and plasma of patients with acute pancreatitisC J Springer, G A Eberlein, V E Eysselein, et al.
Human Gene Therapy|April 10, 1997
The bystander effect of the nitroreductase/CB1954 enzyme/prodrug system is due to a cell-permeable metaboliteJ A Bridgewater, R J Knox, J D Pitts, et al.
Journal of Medicinal Chemistry|February 1, 1990
Novel prodrugs which are activated to cytotoxic alkylating agents by carboxypeptidase G2C J Springer, P Antoniw, K D Bagshawe, et al.
Human Gene Therapy|February 19, 2000
Regressions of established breast carcinoma xenografts by carboxypeptidase G2 suicide gene therapy and the prodrug CMDA are due to a bystander effectS M Stribbling, F Friedlos, J Martin, et al.
Journal of Medicinal Chemistry|April 30, 2004
Significant differences in biological parameters between prodrugs cleavable by carboxypeptidase G2 that generate 3,5-difluoro-phenol and -aniline nitrogen mustards in gene-directed enzyme prodrug therapy systemsI Niculescu-Duvaz, I Scanlon, D Niculescu-Duvaz, et al.
The EMBO Journal|April 16, 1999
Serine and tyrosine phosphorylations cooperate in Raf-1, but not B-Raf activationC S Mason, C J Springer, R G Cooper, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1997
Biodistribution of an antibody-enzyme conjugate for antibody-directed enzyme prodrug therapy in nude mice bearing a human colon adenocarcinoma xenograftS M Stribbling, J Martin, R B Pedley, et al.
Journal of Medicinal Chemistry|July 8, 1999
Self-immolative anthracycline prodrugs for suicide gene therapyI Niculescu-Duvaz, D Niculescu-Duvaz, F Friedlos, et al.
European Journal of Cancer (Oxford, England : 1990)|December 1, 1995
Expression of the bacterial nitroreductase enzyme in mammalian cells renders them selectively sensitive to killing by the prodrug CB1954J A Bridgewater, C J Springer, R J Knox, et al.
Current Opinion in Molecular Therapeutics|November 21, 2001
Recent developments in gene-directed enzyme prodrug therapy (GDEPT) for cancerI Niculescu-Duvaz, R G Cooper, S M Stribbling, et al.
Pageof 7

Showing results (31-40 of 63) with videos related to

Sort By:
Pageof 7
Clinica Chimica Acta; International Journal of Clinical Chemistry|May 15, 1991
Accelerated in vitro degradation of CCK-58 in blood and plasma of patients with acute pancreatitisC J Springer, G A Eberlein, V E Eysselein, et al.
Human Gene Therapy|April 10, 1997
The bystander effect of the nitroreductase/CB1954 enzyme/prodrug system is due to a cell-permeable metaboliteJ A Bridgewater, R J Knox, J D Pitts, et al.
Journal of Medicinal Chemistry|February 1, 1990
Novel prodrugs which are activated to cytotoxic alkylating agents by carboxypeptidase G2C J Springer, P Antoniw, K D Bagshawe, et al.
Human Gene Therapy|February 19, 2000
Regressions of established breast carcinoma xenografts by carboxypeptidase G2 suicide gene therapy and the prodrug CMDA are due to a bystander effectS M Stribbling, F Friedlos, J Martin, et al.
Journal of Medicinal Chemistry|April 30, 2004
Significant differences in biological parameters between prodrugs cleavable by carboxypeptidase G2 that generate 3,5-difluoro-phenol and -aniline nitrogen mustards in gene-directed enzyme prodrug therapy systemsI Niculescu-Duvaz, I Scanlon, D Niculescu-Duvaz, et al.
The EMBO Journal|April 16, 1999
Serine and tyrosine phosphorylations cooperate in Raf-1, but not B-Raf activationC S Mason, C J Springer, R G Cooper, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1997
Biodistribution of an antibody-enzyme conjugate for antibody-directed enzyme prodrug therapy in nude mice bearing a human colon adenocarcinoma xenograftS M Stribbling, J Martin, R B Pedley, et al.
Journal of Medicinal Chemistry|July 8, 1999
Self-immolative anthracycline prodrugs for suicide gene therapyI Niculescu-Duvaz, D Niculescu-Duvaz, F Friedlos, et al.
European Journal of Cancer (Oxford, England : 1990)|December 1, 1995
Expression of the bacterial nitroreductase enzyme in mammalian cells renders them selectively sensitive to killing by the prodrug CB1954J A Bridgewater, C J Springer, R J Knox, et al.
Current Opinion in Molecular Therapeutics|November 21, 2001
Recent developments in gene-directed enzyme prodrug therapy (GDEPT) for cancerI Niculescu-Duvaz, R G Cooper, S M Stribbling, et al.
Pageof 7